Modular Medical, Inc. (MODD)
USD 0.89
(-8.75%)
USD 0.89
(-8.75%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 13.8 Million USD | 90.57% |
| 2023 | 7.24 Million USD | -26.42% |
| 2022 | 9.84 Million USD | 337.98% |
| 2021 | 2.24 Million USD | -41.74% |
| 2020 | 3.85 Million USD | -42.0% |
| 2019 | 6.65 Million USD | 53.49% |
| 2018 | 4.33 Million USD | 215.83% |
| 2017 | 1.37 Million USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 2500.00 USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 76.00 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 13.8 Million USD | 90.57% |
| 2024 Q3 | 6.19 Million USD | -38.37% |
| 2024 Q1 | 13.66 Million USD | 88.62% |
| 2024 Q2 | 10.05 Million USD | -26.39% |
| 2024 Q4 | 13.8 Million USD | 122.73% |
| 2023 FY | 7.24 Million USD | -26.42% |
| 2023 Q2 | 11.43 Million USD | -20.8% |
| 2023 Q1 | 14.44 Million USD | 46.67% |
| 2023 Q4 | 7.24 Million USD | -17.09% |
| 2023 Q3 | 8.73 Million USD | -23.6% |
| 2022 Q4 | 9.84 Million USD | 1209.65% |
| 2022 FY | 9.84 Million USD | 337.98% |
| 2022 Q3 | 751.83 Thousand USD | -45.31% |
| 2022 Q2 | 1.37 Million USD | -65.99% |
| 2022 Q1 | 4.04 Million USD | 79.8% |
| 2021 Q2 | 2.19 Million USD | -42.43% |
| 2021 FY | 2.24 Million USD | -41.74% |
| 2021 Q4 | 2.24 Million USD | 74.07% |
| 2021 Q3 | 1.29 Million USD | -41.28% |
| 2021 Q1 | 3.82 Million USD | -1.0% |
| 2020 Q4 | 3.85 Million USD | -0.63% |
| 2020 FY | 3.85 Million USD | -42.0% |
| 2020 Q1 | 5.79 Million USD | -12.82% |
| 2020 Q2 | 4.88 Million USD | -15.76% |
| 2020 Q3 | 3.88 Million USD | -20.52% |
| 2019 Q2 | 3.73 Million USD | -8.5% |
| 2019 Q3 | 7.22 Million USD | 93.31% |
| 2019 FY | 6.65 Million USD | 53.49% |
| 2019 Q4 | 6.65 Million USD | -7.94% |
| 2019 Q1 | 4.08 Million USD | -5.73% |
| 2018 Q2 | 4.78 Million USD | 248.33% |
| 2018 FY | 4.33 Million USD | 215.83% |
| 2018 Q1 | 1.37 Million USD | 249.82% |
| 2018 Q3 | 4.53 Million USD | -5.18% |
| 2018 Q4 | 4.33 Million USD | -4.38% |
| 2017 FY | 1.37 Million USD | 0.0% |
| 2017 Q4 | 392.31 Thousand USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 FY | - USD | -100.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q2 | 625.00 USD | -75.0% |
| 2016 Q3 | - USD | -100.0% |
| 2016 Q1 | 2500.00 USD | -42.86% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | 2500.00 USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | 4375.00 USD | -30.0% |
| 2015 Q3 | 6250.00 USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | -100.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q3 | 76.00 USD | 0.0% |
| 2005 Q4 | 76.00 USD | 0.0% |
| 2005 Q2 | 76.00 USD | 0.0% |
| 2005 FY | - USD | -100.0% |
| 2004 FY | 76.00 USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 55.981% |
| BrainsWay Ltd. | 62.97 Million USD | 78.074% |
| Cerus Corporation | 197.74 Million USD | 93.018% |
| Envoy Medical, Inc. | 7.64 Million USD | -80.72% |
| electroCore, Inc. | 16.38 Million USD | 15.744% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -79.498% |
| IceCure Medical Ltd | 16.41 Million USD | 15.862% |
| Inogen, Inc. | 326.19 Million USD | 95.767% |
| OrthoPediatrics Corp. | 449.58 Million USD | 96.929% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 49.369% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 16.72% |
| MaxCyte, Inc. | 268.27 Million USD | 94.853% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -70.513% |
| Nexalin Technology, Inc. | 3.63 Million USD | -280.157% |
| Orthofix Medical Inc. | 925.31 Million USD | 98.508% |
| PAVmed Inc | 33.11 Million USD | 58.311% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 90.375% |
| RxSight, Inc. | 182.55 Million USD | 92.437% |
| Sight Sciences, Inc. | 166.65 Million USD | 91.715% |
| SI-BONE, Inc. | 230.42 Million USD | 94.008% |
| TELA Bio, Inc. | 78.04 Million USD | 82.31% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 94.519% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -28.677% |
| Acutus Medical, Inc. | 53.96 Million USD | 74.413% |
| Talis Biomedical Corporation | 98.34 Million USD | 85.96% |
| Spectral AI, Inc. | 10.69 Million USD | -29.134% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 93.685% |
| CVRx, Inc. | 115.22 Million USD | 88.018% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 76.463% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -343.206% |
| Bioventus Inc. | 810.91 Million USD | 98.297% |
| Venus Concept Inc. | 93.65 Million USD | 85.257% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 46.328% |
| LivaNova PLC | 2.42 Billion USD | 99.432% |
| 908 Devices Inc. | 202.98 Million USD | 93.198% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 98.285% |
| Nemaura Medical Inc. | 14.56 Million USD | 5.193% |
| NeuroPace, Inc. | 107.65 Million USD | 87.174% |
| LENSAR, Inc. | 69.58 Million USD | 80.158% |
| Apyx Medical Corporation | 79.24 Million USD | 82.576% |
| Cutera, Inc. | 346.29 Million USD | 96.013% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 67.139% |
| BioSig Technologies, Inc. | 1.79 Million USD | -667.909% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 94.898% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 67.636% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.635% |
| Axonics, Inc. | 719.92 Million USD | 98.082% |
| Outset Medical, Inc. | 313.8 Million USD | 95.6% |
| IRIDEX Corporation | 34.43 Million USD | 59.905% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 96.588% |
| IRadimed Corporation | 92.15 Million USD | 85.018% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -162.79% |
| INVO Bioscience, Inc. | 20.88 Million USD | 33.899% |
| Telesis Bio, Inc. | 70.41 Million USD | 80.391% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 91.04% |
| Varex Imaging Corporation | 1.24 Billion USD | 98.895% |
| Quipt Home Medical Corp. | 247.4 Million USD | 94.419% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -48.303% |
| Pulmonx Corporation | 178.95 Million USD | 92.284% |
| Dynatronics Corporation | 25.94 Million USD | 46.774% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -28.713% |
| Semler Scientific, Inc. | 78.06 Million USD | 82.313% |
| InMode Ltd. | 863.28 Million USD | 98.401% |
| Bruker Corporation | 4.24 Billion USD | 99.675% |
| Cytosorbents Corporation | 53.26 Million USD | 74.077% |
| DexCom, Inc. | 6.26 Billion USD | 99.78% |
| Align Technology, Inc. | 6.08 Billion USD | 99.773% |
| Viveve Medical, Inc. | 25.91 Million USD | 46.718% |
| ZimVie Inc. | 1.2 Billion USD | 98.855% |
| Movano Inc. | 9.42 Million USD | -46.556% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 97.226% |
| Nexalin Technology, Inc. | 3.63 Million USD | -280.157% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 76.463% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 98.551% |
| Profound Medical Corp. | 43.68 Million USD | 68.395% |
| Insulet Corporation | 2.58 Billion USD | 99.467% |
| enVVeno Medical Corporation | 48.63 Million USD | 71.611% |
| Surmodics, Inc. | 185.73 Million USD | 92.566% |
| iCAD, Inc. | 41.41 Million USD | 66.664% |
| Nuwellis, Inc. | 9.77 Million USD | -41.32% |
| Biotricity, Inc. | 5.94 Million USD | -132.338% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 96.812% |
| Aethlon Medical, Inc. | 8.24 Million USD | -67.439% |
| InspireMD, Inc. | 47.64 Million USD | 71.02% |
| PAVmed Inc. | 33.11 Million USD | 58.311% |
| BIOLASE, Inc. | 35.1 Million USD | 60.665% |
| Beyond Air, Inc. | 56.96 Million USD | 75.761% |
| FONAR Corporation | 214.24 Million USD | 93.556% |
| AxoGen, Inc. | 196.82 Million USD | 92.985% |
| Vivani Medical, Inc. | 45.79 Million USD | 69.852% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 95.094% |
| Inari Medical, Inc. | 674.23 Million USD | 97.952% |
| UFP Technologies, Inc. | 404.13 Million USD | 96.584% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 40.992% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -45.289% |
| Tenon Medical, Inc. | 6.34 Million USD | -117.604% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -46.774% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 86.679% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.701% |
| Sintx Technologies, Inc. | 15.36 Million USD | 10.14% |
| NanoVibronix, Inc. | 6.67 Million USD | -106.877% |
| Quanterix Corporation | 425.01 Million USD | 96.751% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -48.303% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 74.302% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.209% |
| TransMedics Group, Inc. | 706.04 Million USD | 98.044% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 78.151% |
| NeuroMetrix, Inc. | 21.42 Million USD | 35.555% |
| Hyperfine, Inc. | 94.19 Million USD | 85.343% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 94.86% |
| Biomerica, Inc. | 9.25 Million USD | -49.2% |
| Bone Biologics Corporation | 3.73 Million USD | -269.392% |
| AVITA Medical, Inc. | 144.33 Million USD | 90.434% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -183.597% |
| Silk Road Medical, Inc | 265.3 Million USD | 94.796% |